Related Experiment Videos
Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population
A Steinmetz1, A Kirklies, G Schlosser
1Zentrum Innere Medizin, Abteilungen Endokrinologie und Stoffwechsel, Philipps-Universität Marburg.
Insights
Intermediate-density lipoproteins (IDL) correlate with blood pressure, unlike lipoprotein (a) [Lp(a)]. This suggests different mechanisms for these atherosclerosis risk factors.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Hypertension Research
Background:
- Hypercholesterolemia and hypertension are key risk factors for atherosclerotic vascular disease.
- Elevated intermediate-density lipoproteins (IDL) and low-density lipoproteins (LDL) are atherogenic.
- Lipoprotein (a) [Lp(a)] is another identified risk factor for atherosclerosis.
Purpose of the Study:
- To investigate the relationship between IDL and Lp(a) levels and systemic blood pressure.
- To compare these correlations with known associations between cholesterol and blood pressure.
- To explore potential differences in the metabolic pathways of IDL, LDL, and Lp(a).
Main Methods:
- Studied 200 male employees (mean age 26 ± 7 years).
- Measured blood pressure multiple times per individual.
- Determined serum levels of lipids, lipoprotein cholesterol, apolipoprotein B (apo B), and Lp(a).
Main Results:
- IDL cholesterol and apo B showed a correlation with blood pressure.
- Lp(a) levels did not correlate with systolic or diastolic blood pressure.
- Lp(a) levels were not associated with lipoprotein cholesterol, body weight, or age.
Conclusions:
- IDL, but not Lp(a), is related to systemic blood pressure in this cohort.
- These findings suggest distinct metabolic and pathophysiological mechanisms for IDL, LDL, and Lp(a).
- Further research into these differences may reveal new therapeutic targets for atherosclerosis.
Abstract:
Both hypercholesterolemia and hypertension are risk factors for atherosclerotic vascular disease, and elevated cholesterol levels occur more frequently than expected in patients with hypertension. Elevated levels of intermediate-density lipoproteins (IDL) and low-density lipoproteins (LDL) were shown to be atherogenic, and LDL, comprising the major cholesterol-carrying fraction in human plasma, are structurally related to lipoprotein (a)[Lp(a)], a further risk factor for atherosclerosis. In the present study we investigated 200 male employees (mean age 26 +/- 7 years) to determine whether the relationship of IDL and Lp(a) to systemic blood pressure is similar to the reported correlations between total and LDL cholesterol and systemic blood pressure. To this end blood pressure was measured several times in each individual, and lipids, lipoprotein-cholesterol, apolipoprotein B (apo B), and Lp(a) were determined in fasting serum. IDL cholesterol and apo B, the main protein component of IDL and LDL correlated with blood pressure. However, levels of Lp(a) correlated neither with systolic or diastolic blood pressure nor with lipoprotein cholesterol, body weight, or age. Although IDL and Lp(a) are considered lipoprotein risk factors for atherosclerosis, levels of Lp(a), unlike IDL, are not related to blood pressure, body weight, or age. Our data suggest different metabolic and pathophysiological mechanisms of the risk factors, IDL, LDL, and Lp(a).